Raymond James initiates Quince Therapeutics at Outperform
Raymond James initiated coverage of Quince Therapeutics with an Outperform rating, according to Benzinga’s ratings actions recap.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.